Safe Harbor Financial Modifies Commercial Alliance Agreement with Partner Colorado Credit Union
GOLDEN, Colo., Jan. 07, 2025 (GLOBE NEWSWIRE) — SHF Holdings, Inc., d/b/a/ Safe Harbor Financial (“Safe Harbor” or the “Company”) […]
Cassava Sciences Provides a Business Update
Topline data from Phase 3 REFOCUS-ALZ study of simufilam in patients with mild-to-moderate Alzheimer’s disease expected late first-quarter/early second-quarter 2025 […]
Lands’ End Announces Participation in the 27th Annual ICR Conference
DODGEVILLE, Wis., Jan. 07, 2025 (GLOBE NEWSWIRE) — Lands’ End, Inc. (NASDAQ: LE) today announced that the Company will be […]
First Western Financial, Inc. to Report Fourth Quarter 2024 Financial Results on Thursday, January 23
DENVER, Jan. 07, 2025 (GLOBE NEWSWIRE) — First Western Financial, Inc. (NASDAQ: MYFW), a financial services holding company headquartered in […]
Renasant Announces 2024 Fourth Quarter Webcast and Conference Call Information
TUPELO, Miss., Jan. 07, 2025 (GLOBE NEWSWIRE) — Renasant Corporation (NYSE: RNST) (the “Company”) will announce 2024 fourth quarter results […]
Michigan Circuit Court Approves Order for the Appointment of Receiver over Pharmaco Assets
TORONTO, Jan. 07, 2025 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) confirms […]
California Water Service Group Promotes Kenneth G. Jenkins to Vice President, Water Resources Planning and Sustainability
SAN JOSE, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) — California Water Service Group (Group) (NYSE:CWT) today announced the promotion of […]
MidCap Financial Investment Corporation Schedules Earnings Release and Conference Call for Quarter and Fiscal Year Ended December 31, 2024
NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) — MidCap Financial Investment Corporation (NASDAQ: MFIC) (the “Company”) announced today that it […]
Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich’s Ataxia
– SGT-212 is the only full-length frataxin replacement gene therapy candidate targeting the CNS and cardiac manifestations of Friedreich’s ataxia […]
Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility
HINGHAM, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously […]
